raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:319298

Papillary renal cell carcinoma

Synonyms: Papillary renal cell adenocarcinoma

Type
Disease
Group
Disorder
Inheritance
Not applicable
Age of onset
Adult, Elderly
Status
active

Papillary renal cell carcinoma is a rare subtype of renal cell carcinoma, arising from the renal tubular epithelium and showing a papillary growth pattern, which typically manifests with hematuria, flank pain, palpable abdominal mass or nonspecific symptoms, such as fatigue, weight loss or fever. Symptoms related to metastatic spread, such as bone pain or persistent cough, are frequently associated since early diagnosis is not common. It is typically multifocal, bilateral, and in most cases sporadic, although different hereditary syndromes, such as Hereditary leiomyoma renal cell carcinoma, Birt-Hogg-Dubé syndrome and Tuberous sclerosis, may predispose to the development of papillary renal cell carcinoma.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enPapillary renal cell carcinomaPapillary renal cell adenocarcinoma
frCarcinome rénal papillaireAdénocarcinome rénal papillaire
deNierenzellkarzinom, papilläresPapilläres Adenokarzinom der Niere
esCarcinoma papilar de células renalesAdenocarcinoma papilar renal
itCarcinoma papillare delle cellule renaliAdenocarcinoma papillare delle cellule renali
nlPapillair niercelcarcinoomPapillair nierceladenocarcinoom
ptCarcinoma de células renais papilar
plRak brodawkowaty nerki= en
csPapilární renální karcinomPapilární renální adenokarcinom
ukПапілярна нирковоклітинна карциномаПапілярна нирковоклітинна аденокарцинома
zh乳头状肾细胞癌乳头状肾细胞腺癌
trPapiller renal hücreli karsinomPapiller renal hücreli adenokarsinom

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10C64NTBTattributedvalidated
ICD-112C90.YNTBTindexvalidated
MONDO0017884Evalidated
UMLSC1306837Evalidated
GARD9572Evalidated
MedDRA10078493Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

2 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
METDisease-causing somatic mutation(s) inAssessedHGNC:7029ENSG000001059761648607q31.2MET proto-oncogene, receptor tyrosine kinase26536169[PMID]
MITFMajor susceptibility factor inAssessedHGNC:7105ENSG000001870981568453p13melanocyte inducing transcription factor22012259[PMID]
5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Annual incidence1-9 / 1 000 0000.14 / 100 000EuropeValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card